Clinical Trial: Growth And Safety Outcomes In Infants With Cow's Milk Protein Allergy (CMPA) Fed A Novel Extensively Hydrolyzed Formula (eHF)

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07711938) titled 'Growth And Safety Outcomes In Infants With Cow's Milk Protein Allergy (CMPA) Fed A Novel Extensively Hydrolyzed Formula (eHF)' on June 22.

Brief Summary: Growth and safety Outcomes in infants with CMPA fed a novel extensively hydrolyzed formula.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Cow Milk Protein Allergy

Intervention: DIETARY_SUPPLEMENT: New generation eHF

New generation of a whey-based eHF formula intended for the dietary management of infants with CMPA.

DIETARY_SUPPLEMENT: Commercial eHF

Commercial whey-based eHF formula intended for the dietary management of infants with CMPA.

Recruitment St...